A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: Perspective of the Spanish National Health System
- Paz-Ares, L.
- Del Muro, J.G.
- Grande, E.
- Díaz, S.
ISSN: 0269-4727, 1365-2710
Year of publication: 2010
Volume: 35
Issue: 4
Pages: 429-438
Type: Article